Jin Y, Sun A, Noriki S, Imamura Y, Fukuda M
Department of Oncological Pathology, University of Fukui, Matsuoka, Eiheiji-cho, Yoshida-Gun, Fukui, Japan.
Eur J Histochem. 2007 Jan-Mar;51(1):1-10.
An immunohistochemical differential staining of cancerous cells with anti-cytidine antibody after denaturation of nuclear DNA by acid hydrolysis with 2N HCl at 30 degrees C for 20 min (DNA-instability test) has been used as a marker for malignancy. The test was applied to bioptic tissues of human colorectal polyps assessed histopathologically as hyperplastic polyp (11 cases), tubular adenoma of mild (68 cases), moderate (102 cases), and severe (46 cases) dysplasia, and adenocarcinoma (30 cases). The serial sections of the same tissues were also subjected to immunohistochemical staining for Ki67, p53, DNA-fragmentation factor 45 (DFF45) and vascular endothelial growth factor (VEGF). The DNA-instability test was positive in 30 (100%) adenocarcinoma cases, 46 (100%) severe dysplasia adenoma cases, 36 (35.29%) moderate dysplasia adenoma cases, and 8 (11.76%) mild dysplasia adenoma cases, indicating malignancy. All hyperplastic polyps were negative to the DNA-instability test. Furthermore, the percentage of glands positive in the DNA-instability test steadily increased in going from mild (10%), to moderate (35%), to severe (100%) dysplasia, and adenocarcinoma (100%). All other biological markers tested in the present study showed significantly higher values in those adenoma glands that were positive to the DNA-instability test, irrespective of the dysplasia grade, as compared to the markers in the adenoma glands that were negative to DNA instability testing. Furthermore, the former values were comparable to those in adenocarcinoma. The results indicate that cancer cell clones are already present at the adenoma stages showing positivity to DNA instability testing, enhanced proliferative activity, p53 mutation and induction of DFF45 and VEGF, at a time when the degree of morphological atypia are not yet large enough for them to be identified as cancer. These factors promote cancer cell proliferation, produce heterogeneous subclones due to DNA instability, enhance their survival by escaping apoptosis, and provide abundant nutrients by neovascularization during the early-stage progression of colorectal cancer.
通过在30℃下用2N盐酸酸水解20分钟使核DNA变性后,用抗胞嘧啶抗体对癌细胞进行免疫组织化学差异染色(DNA不稳定性测试)已被用作恶性肿瘤的标志物。该测试应用于经组织病理学评估为增生性息肉(11例)、轻度(68例)、中度(102例)和重度(46例)发育异常的管状腺瘤以及腺癌(30例)的人结肠息肉活检组织。相同组织的连续切片也进行了Ki67、p53、DNA片段化因子45(DFF45)和血管内皮生长因子(VEGF)的免疫组织化学染色。DNA不稳定性测试在30例(100%)腺癌病例、46例(100%)重度发育异常腺瘤病例、36例(35.29%)中度发育异常腺瘤病例和8例(11.76%)轻度发育异常腺瘤病例中呈阳性,表明为恶性肿瘤。所有增生性息肉的DNA不稳定性测试均为阴性。此外,DNA不稳定性测试阳性腺体的百分比从轻度(10%)、到中度(35%)、到重度(100%)发育异常以及腺癌(100%)稳步增加。与DNA不稳定性测试阴性的腺瘤腺体中的标志物相比,本研究中测试的所有其他生物学标志物在DNA不稳定性测试阳性的腺瘤腺体中显示出显著更高的值,无论发育异常程度如何。此外,前者的值与腺癌中的值相当。结果表明,在形态学异型程度尚未大到足以被识别为癌症时,癌细胞克隆已经存在于腺瘤阶段,表现为对DNA不稳定性测试呈阳性、增殖活性增强、p53突变以及DFF45和VEGF的诱导。这些因素促进癌细胞增殖,由于DNA不稳定性产生异质亚克隆,通过逃避凋亡提高其存活率,并在结直肠癌的早期进展过程中通过新生血管形成提供丰富的营养。